ResMed (RMD) Tops Q1 EPS by 15c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $224.99 -1.5%
EPS Growth %: +5.5%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +5.5%
Financial Fact:
Other, net (note 12): 1.27M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $2.20, $0.15 better than the analyst estimate of $2.05. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.19 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Ximen Mining launches $350,000 bridge placement for Kenville mine
- Teva shares Phase 3 data on once-monthly schizophrenia injection
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
